newsfilter
← Latest News
GlobeNewswire·

CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025

- 71 patients dosed in the potentially pivotal Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023, CARGO's